Procaps Group (PROC): Total Asset Value of Company

Graphic logo of Procaps Group SA (PROC)

This price chart visualizing the trading dynamics of Procaps Group S.A. (PROC) total assets helps assess resilience to geopolitical risks and raw material logistics disruptions. The current indicator stands at 0.00, which is critical amid internal reorganization and liquidity shortages. Meanwhile, the business leverages its status as the leading softgel manufacturer in Latin America, benefiting from the unconditional recognition of global B2B partners.

Procaps Group S.A. (PROC) Company Total Assets: for the period 07/04/2022 - 02/16/2025

Comprehensive metric breakdowns and analytics for Procaps Group SA (PROC)

- price and consensus price forecast:
Stock Quotes procapsgroup.com|PROC - Price Target Chart
- market capitalization data:
Market Valuation Procaps Group Corp|PROC - Enterprise Value
- book capitalization data:
Accounting Value of a Share Procaps|PROC - Book Capitalization|Market Capitalization to Book Value Ratio procapsgroup.com|PROC - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Procaps Group S.A.|PROC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Procaps Group Corp|PROC - Company Aggregate Debts|Debts to Book Capitalization Procaps Group Corp
Fundamental valuation:PROC, procapsgroup.com
Finished products of Procaps Group S.A.

The diversified business model of Procaps Group S.A. (PROC) focusing on softgel capsules and contract manufacturing requires a stable resource base, which, through an analysis of total capital and liabilities on GURU.Markets, reflects the total value of controlled assets. This indicator, reverse-calculated via current ROA and market capitalization, allows investors to track liquidity dynamics and the risk of frozen funds between quarterly reports.

Competitors of Procaps Group S.A. (PROC)

HLN (haleon.com) - Cumulative Company Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value ORMP (oramed.com)|Entera Bio (ENTX) - Aggregate Company Assets|MindWalk Holdings, Inc. - Total Asset Value of Company|Aggregate Company Assets ABVC BioPharma Inc (ABVC)|CPIX: Aggregate Asset Value|Aggregate Company Assets QNTM|fibrogen.com (FGEN) - Company Assets|Company Total Assets TELO|Cumulative Company Assets Rani Therapeutics Inc|Company Total Assets SNYR|Company Total Assets RLYB (rallybio.com)|Lexaria Bioscience Corp. (LEXX) - Aggregate Company Assets|pulmatrix.com - Total Asset Value of Company|Aggregate Company Assets PTHL (Pheton)|Aptorum Group Limited (APM) - Company Total Asset Base|Cumulative Company Assets Lyra Therapeutics, Inc LYRA|Impact BioMedical, Inc. (IBO) - Aggregate Asset Value|TNF Pharmaceuticals Inc. - Company Total Assets|Company Balance Sheet Assets YCBD|PainReform (PRFX) - Aggregate Company Assets|Aggregate Asset Value CYTO (altamiratherapeutics.com)|LIPO: Aggregate Company Assets|OPTN - Company Assets|Pieris Pharmaceuticals - Cumulative Company Assets|PTPI: Company Total Assets|Aggregate Company Assets Qilian International Holding (QLI)|Total Asset Value of Company Acelyrin Inc.|TFFP - Cumulative Company Assets